Cite

1. SIEGEL R, MA J, ZOU Z, JEMAL A. Cancer statistics. CA Cancer J Clin. 2014; 64:9–29.10.3322/caac.2120824399786 Search in Google Scholar

2. RAWLA P, SUNKARA T, GADUPUTI V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10(1):10–27.10.14740/wjon1166639677530834048 Search in Google Scholar

3. ZABRON A, EDWARDS RJ, KHAN SA. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Dis Model Mech. 2013;6(2):281–292.10.1242/dmm.010561359701123520144 Search in Google Scholar

4. GOUMA DJ, VAN GEENEN R, VAN GULIK T, DE WIT LT, OBERTOP H. Surgical palliative treatment in bilio-pancreatic malignancy. Ann Oncol. 1999;10 Suppl 4:269–272.10.1023/A:1008328802484 Search in Google Scholar

5. AMERICAN CANCER SOCIETY. Survival rates for bile duct cancer [online]. 2019 https://www.cancer.org/cancer/bile-duct-cancer/detection-diagnosisstaging/survival-by-stage.html. Search in Google Scholar

6. KIRSTEIN MM, VOGEL A. Epidemiology and Risk Factors of Cholangiocarcinoma [published correction appears in Visc Med. 2017 Jun;33(3):226]. Visc Med. 2016;32(6):395–400.10.1159/000453013529044628229073 Search in Google Scholar

7. HUANG L, JANSEN L, BALAVARCA Y, BABAEI M, VAN DER GEEST L, LEMMENS V, et al. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study. BMC Med. 2018;16(1):125.10.1186/s12916-018-1120-9610280430126408 Search in Google Scholar

8. MIHALACHE F, TANTAU M, DIACONU B, ACALOVSCHI M. Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period. J Gastrointestin Liver Dis. 2010;19(3):285–290. Search in Google Scholar

9. KAASSIS M, BOYER J, DUMAS R, PONCHON T, COUMAROS D, DELCENSERIE R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003;57(2): 178–182.10.1067/mge.2003.6612556780 Search in Google Scholar

10. LA VECCHIA C, ROTA M, MALVEZZI M, NEGRI E. Potential for improvement in cancer management: reducing mortality in the European Union. Oncologist. 2015;20(5):495–498.10.1634/theoncologist.2015-0011442539425888268 Search in Google Scholar

11. Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(8):1028–1061.10.6004/jnccn.2017.013128784865 Search in Google Scholar

12. BENSON AB 3RD, ABRAMS TA, BEN-JOSEF E, BLOOMSTON MP, BOTHA JF, CLARY BM, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009;7(4):350–391.10.6004/jnccn.2009.0027446114719406039 Search in Google Scholar

13. CONILL C, VERGER E, SALAMERO M. Performance status assessment in cancer patients. Cancer. 1990;65(8):1864–1866.10.1002/1097-0142(19900415)65:8<1864::AID-CNCR2820650832>3.0.CO;2-U Search in Google Scholar

14. VALERO V 3RD, COSGROVE D, HERMAN JM, PAWLIK TM. Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol. 2012;6(4):481–495.10.1586/egh.12.20 Search in Google Scholar

15. HOFMARCHER T, LINDGREN P, WILKING N, JÖNSSON B. The cost of cancer in Europe 2018. European Journal of Cancer 129:41–49.10.1016/j.ejca.2020.01.011 Search in Google Scholar

16. GAŃCZAK M, MIAZGOWSKI T, KOŻYBSKA M, KOTWAS A, KORZEŃ M, RUDNICKI B, et al. Changes in disease burden in Poland between 1990–2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017. PLoS One. 2020 Mar 2;15(3):e022676610.1371/journal.pone.0226766 Search in Google Scholar

17. CHARI ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34(4):284–294.10.1053/j.seminoncol.2007.05.005 Search in Google Scholar

18. PIANO M, BLACK G, AMELUNG D, POWER E, WHITAKER KL. Exploring public attitudes towards the new Faster Diagnosis Standard for cancer: a focus group study with the UK public. Br J Gen Pract. 2019;69(683):e413–e421.10.3399/bjgp19X702677 Search in Google Scholar

19. KHAN SA, DAVIDSON BR, GOLDIN R, PEREIRA SP, ROSENBERG WMC, TAYLOR-ROBINSON SD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51 Suppl 6(Suppl 6):VI1–VI9.10.1136/gut.51.suppl_6.vi1 Search in Google Scholar

20. JEMAL A, MURRAY T, WARD E, SAMUELS A, TIWARI RC, GHAFOOR A, et al. Cancer statistics, 2005 [published correction appears in CA Cancer J Clin. 2005 Jul-Aug;55(4):259]. CA Cancer J Clin. 2005;55(1):10–30.10.3322/canjclin.55.1.10 Search in Google Scholar

21. VINCENT A, HERMAN J, SCHULICK R, HRUBAN RH, GOGGINS M. Pancreatic cancer. Lancet. 2011;378(9791): 607–620.10.1016/S0140-6736(10)62307-0 Search in Google Scholar

22. SCHEITHAUER W, PUTORA PM, GRÜNBERGER B, EISTERER W, WÖLL E, PRAGER G, et al. Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine [published correction appears in Therap Adv Gastroenterol. 2019 Sep 23;12:175628481987763510.1177/1756284819877635 Search in Google Scholar

23. PEIXOTO RD, RENOUF D, LIM H. A population based analysis of prognostic factors in advanced biliary tract cancer. J Gastrointest Oncol. 2014;5(6):428–432. Search in Google Scholar

24. HUIBREGTSE K, CARR-LOCKE DL, CREMER M, DOMSCHKE W, FOCKENS P, FOERSTER E, et al. Biliary stent occlusion-a problem solved with self-expanding metal stents? European Wallstent Study Group. Endoscopy. 1992;24(5): 391–394.10.1055/s-2007-10105051505486 Search in Google Scholar

25. KNYRIM K, WAGNER HJ, PAUSCH J, VAKIL N. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy. 1993;25(3):207–212.10.1055/s-2007-10102948519239 Search in Google Scholar

26. MOY BT, BIRK JW. An Update to Hepatobiliary Stents. J Clin Transl Hepatol. 2015;3(1):67–77.10.14218/JCTH.2015.00040454208126357636 Search in Google Scholar

27. SCHMIDT M, SCHMIDT SAJ, ADELBORG K, SUNDBØLL J, LAUGESEN K, EHRENSTEIN V, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563-591.10.2147/CLEP.S179083663426731372058 Search in Google Scholar

28. HIRIPI, E., GONDOS, A., EMRICH, K., HOLLECZEK, B., KATALINIC, A., LUTTMANN, S. Survival from common and rare cancers in Germany in the early 21st century. Annals of Oncology 2011; 23(2):472–479.10.1093/annonc/mdr13121597096 Search in Google Scholar

29. DEYO D, KHALIQ A, MITCHELL D, HUGHES DR. Electronic sharing of diagnostic information and patient outcomes. Am J Manag Care. 2018;24(1):32–37 Search in Google Scholar

30. KRUSE CS, KRISTOF C, JONES B, MITCHELL E, MARTINEZ A. Barriers to Electronic Health Record Adoption: a Systematic Literature Review. J Med Syst. 2016 Dec;40(12):252.10.1007/s10916-016-0628-9505404327714560 Search in Google Scholar

31. GAVIN DR, VALORI RM, ANDERSON JT, DONNELLY MT, WILLIAMS JG, SWARBRICK ET. The national colonoscopy audit: a nationwide assessment of the quality and safety of colonoscopy in the UK. Gut. 2013;62(2):242–9.10.1136/gutjnl-2011-30184822661458 Search in Google Scholar

eISSN:
2501-062X
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Clinical Medicine, Internal Medicine, other, Cardiology, Gastroenterology, Rheumatology